arrow
V

Vincenzo Cerundolo

University of Oxford
H指数:103
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells (vol 15, 3448 , 2024)
2024-04-240
OAAI
Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells

脂蛋白作为脂质抗原递送和不变的自然杀伤T细胞活化的载体

2023-05-086
OA
MAIT cells activate dendritic cells to promote TFH cell differentiation and induce humoral immunity
2023-04-0120
OAAI
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma

地西他滨增加新抗原和癌症睾丸抗原表达以增强T细胞介导的对胶质母细胞瘤的毒性

2022-04-2528
OAAI
The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation

P5-type atp酶ATP13A1调节主要组织相容性复合体I相关蛋白1 (MR1) 介导的抗原呈递

2022-02-017
OAAI
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation
2021-05-0127
OAAI
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses

PLGA纳米颗粒共封装NY-ESO-1肽和IMM60诱导强大的CD8和CD4 T细胞和b细胞反应

2021-02-2526
OAAI
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
MED
IF11.8
2021-02-0168
OAAI
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity
2020-11-2028
OAAI
Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action
MABS
IF7.3
2020-09-035
OAAI
Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

细胞身份和核线粒体遗传背景调节OXPHOS性能并确定体细胞异质动力学

2020-07-3132
OAAI
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model

anti-PD-L1免疫治疗联合放疗对小鼠前列腺癌模型肿瘤免疫微环境的影响

2020-07-0960
OAAI
Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation
2020-07-028
OAAI